Clinical Trial

A Study of ZL-1310 in Participants With Selected Solid Tumors

Name: A Study of ZL-1310 in Participants With Selected Solid Tumors — clinical trial record (NCT06885281)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Protocol Amendment History 3 changes

notable Enrollment increased: 112 -> 166 participants 2026-07-08

minor Completion pushed: 2027-12 -> 2028-04 2026-07-08

notable Trial sites expanded: 16 -> 20 locations 2026-04-10

Trial Details

NCT Number	NCT06885281
Lead Sponsor	Zai Lab (Shanghai) Co., Ltd. Collaborators: Zai Lab (US) LLC
Conditions	Solid Tumors
Enrollment	166 participants
Start Date	2025-05-12
Primary Completion	2027-08 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-07-23